The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications
At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various vo...
Gespeichert in:
Veröffentlicht in: | Annals of surgery 1984, Vol.199 (1), p.37-43 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 43 |
---|---|
container_issue | 1 |
container_start_page | 37 |
container_title | Annals of surgery |
container_volume | 199 |
creator | DUNN, D. L BARKE, R. A AHRENHOLZ, D. H HUMPHREY, E. W SIMMONS, R. L |
description | At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms. |
doi_str_mv | 10.1097/00000658-198401000-00007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1353255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80927479</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-a9199c0dcfbed80564af19f1ba95de09096483d45a8878273d7cb0c11e3431073</originalsourceid><addsrcrecordid>eNpVUU1v3CAURFWjdJv0J1TiUPXmlGfAwKVSFfVLSpVLckYsPLpENt4aO2r_fXHjrlouwMy8YcQQQoFdATPqHVtXJ3UDRgsG9dKsiHpGdiDbCoNgz8muQrwRhrcvyMtSHhgDoZk6J-cd71qp2x053B2QuvCwPLo8U4wR_UzHSI84pXnM6Hoa-yUFmjLFnys6YJ4rugnSnMoV_Yb-4HIqA3U5UN-nnHzVpOHY18OcxlwuyVl0fcFX235B7j99vLv-0tzcfv56_eGm8ZybuXEGjPEs-LjHoJnshItgIuydkQGZYaYTmgchndZKt4oH5ffMAyAXHJjiF-T9k-9x2Q8YfE07ud4ea3A3_bKjS_Z_JqeD_T4-WuCSt1JWg7ebwTT-WLDMdkjFY9-7jONSrGamVUKZKtRPQj-NpUwYT48As2tL9m9L9tTSH2gN-frfkKfBrZbKv9l4V-pHxslln8pJZqSQwIH_Bhp8nG0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80927479</pqid></control><display><type>article</type><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</creator><creatorcontrib>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</creatorcontrib><description>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/00000658-198401000-00007</identifier><identifier>PMID: 6362582</identifier><identifier>CODEN: ANSUA5</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adjuvants, Immunologic - immunology ; Animals ; Ascitic Fluid - immunology ; Ascitic Fluid - microbiology ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Blood - microbiology ; Escherichia coli - growth & development ; Escherichia coli Infections - immunology ; Human bacterial diseases ; Infectious diseases ; Male ; Medical sciences ; Peritoneal Cavity - immunology ; Peritoneal Cavity - microbiology ; Peritonitis - microbiology ; Peritonitis - prevention & control ; Phagocytosis ; Rats ; Sodium Chloride - administration & dosage ; Therapeutic Irrigation</subject><ispartof>Annals of surgery, 1984, Vol.199 (1), p.37-43</ispartof><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1353255/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1353255/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4021,27921,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9545131$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6362582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUNN, D. L</creatorcontrib><creatorcontrib>BARKE, R. A</creatorcontrib><creatorcontrib>AHRENHOLZ, D. H</creatorcontrib><creatorcontrib>HUMPHREY, E. W</creatorcontrib><creatorcontrib>SIMMONS, R. L</creatorcontrib><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</description><subject>Adjuvants, Immunologic - immunology</subject><subject>Animals</subject><subject>Ascitic Fluid - immunology</subject><subject>Ascitic Fluid - microbiology</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Blood - microbiology</subject><subject>Escherichia coli - growth & development</subject><subject>Escherichia coli Infections - immunology</subject><subject>Human bacterial diseases</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Peritoneal Cavity - immunology</subject><subject>Peritoneal Cavity - microbiology</subject><subject>Peritonitis - microbiology</subject><subject>Peritonitis - prevention & control</subject><subject>Phagocytosis</subject><subject>Rats</subject><subject>Sodium Chloride - administration & dosage</subject><subject>Therapeutic Irrigation</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1v3CAURFWjdJv0J1TiUPXmlGfAwKVSFfVLSpVLckYsPLpENt4aO2r_fXHjrlouwMy8YcQQQoFdATPqHVtXJ3UDRgsG9dKsiHpGdiDbCoNgz8muQrwRhrcvyMtSHhgDoZk6J-cd71qp2x053B2QuvCwPLo8U4wR_UzHSI84pXnM6Hoa-yUFmjLFnys6YJ4rugnSnMoV_Yb-4HIqA3U5UN-nnHzVpOHY18OcxlwuyVl0fcFX235B7j99vLv-0tzcfv56_eGm8ZybuXEGjPEs-LjHoJnshItgIuydkQGZYaYTmgchndZKt4oH5ffMAyAXHJjiF-T9k-9x2Q8YfE07ud4ea3A3_bKjS_Z_JqeD_T4-WuCSt1JWg7ebwTT-WLDMdkjFY9-7jONSrGamVUKZKtRPQj-NpUwYT48As2tL9m9L9tTSH2gN-frfkKfBrZbKv9l4V-pHxslln8pJZqSQwIH_Bhp8nG0</recordid><startdate>1984</startdate><enddate>1984</enddate><creator>DUNN, D. L</creator><creator>BARKE, R. A</creator><creator>AHRENHOLZ, D. H</creator><creator>HUMPHREY, E. W</creator><creator>SIMMONS, R. L</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>1984</creationdate><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><author>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-a9199c0dcfbed80564af19f1ba95de09096483d45a8878273d7cb0c11e3431073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adjuvants, Immunologic - immunology</topic><topic>Animals</topic><topic>Ascitic Fluid - immunology</topic><topic>Ascitic Fluid - microbiology</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Blood - microbiology</topic><topic>Escherichia coli - growth & development</topic><topic>Escherichia coli Infections - immunology</topic><topic>Human bacterial diseases</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Peritoneal Cavity - immunology</topic><topic>Peritoneal Cavity - microbiology</topic><topic>Peritonitis - microbiology</topic><topic>Peritonitis - prevention & control</topic><topic>Phagocytosis</topic><topic>Rats</topic><topic>Sodium Chloride - administration & dosage</topic><topic>Therapeutic Irrigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUNN, D. L</creatorcontrib><creatorcontrib>BARKE, R. A</creatorcontrib><creatorcontrib>AHRENHOLZ, D. H</creatorcontrib><creatorcontrib>HUMPHREY, E. W</creatorcontrib><creatorcontrib>SIMMONS, R. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUNN, D. L</au><au>BARKE, R. A</au><au>AHRENHOLZ, D. H</au><au>HUMPHREY, E. W</au><au>SIMMONS, R. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>1984</date><risdate>1984</risdate><volume>199</volume><issue>1</issue><spage>37</spage><epage>43</epage><pages>37-43</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><coden>ANSUA5</coden><abstract>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>6362582</pmid><doi>10.1097/00000658-198401000-00007</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4932 |
ispartof | Annals of surgery, 1984, Vol.199 (1), p.37-43 |
issn | 0003-4932 1528-1140 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1353255 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adjuvants, Immunologic - immunology Animals Ascitic Fluid - immunology Ascitic Fluid - microbiology Bacterial diseases Bacterial diseases of the digestive system and abdomen Biological and medical sciences Blood - microbiology Escherichia coli - growth & development Escherichia coli Infections - immunology Human bacterial diseases Infectious diseases Male Medical sciences Peritoneal Cavity - immunology Peritoneal Cavity - microbiology Peritonitis - microbiology Peritonitis - prevention & control Phagocytosis Rats Sodium Chloride - administration & dosage Therapeutic Irrigation |
title | The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A02%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20adjuvant%20effect%20of%20peritoneal%20fluid%20in%20experimental%20peritonitis.%20Mechanism%20and%20clinical%20implications&rft.jtitle=Annals%20of%20surgery&rft.au=DUNN,%20D.%20L&rft.date=1984&rft.volume=199&rft.issue=1&rft.spage=37&rft.epage=43&rft.pages=37-43&rft.issn=0003-4932&rft.eissn=1528-1140&rft.coden=ANSUA5&rft_id=info:doi/10.1097/00000658-198401000-00007&rft_dat=%3Cproquest_pubme%3E80927479%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80927479&rft_id=info:pmid/6362582&rfr_iscdi=true |